![]() |
|
J.-L. Plantier (1), D. Saboulard (2), J.-L. Pellequer (3), C. Négrier (1), M. Delcourt (2, 4)
(1) Laboratoire d’hémobiologie EA4174-IFR62 Faculté de médecine RTH Laennec, Université de Lyon, Lyon, France; (2) Biométhodes, Evry, France; (3) CEA, iBEB, Service de Biochimie et Toxicologie Nucléaire, Bagnols sur Cèze, France; (4) Present address: Global Bioenergies, Evry, France
Coagulation factor VIII (FVIII) is a multidomain glycoprotein in which the FVIII A2 domain is a key structural element. We aimed at identifying residues within FVIII A2 domain that are crucial for the maintenance of the cofactor function. A high number (n=206) of mutants were generated by substituting original residues with alanine. The mutants were expressed in COS-1 cells and their antigen levels and procoagulant activities were measured. The residues were classified in three categories: those with a non-detrimental alteration of their activities (activity >50 % of control FVIII; n=98), those with a moderate alteration (15 %
factor VIII, Coagulation factors, protein function / activity, protein structure / folding
| 1. | ||
J.-L. Pellequer (1), S.-w. W. Chen (1), D. Saboulard (2), M. Delcourt (2), C. Négrier (3), J.-L. Plantier (3) Thrombosis and Haemostasis 2011 106 1: 121-131 http://dx.doi.org/10.1160/TH10-09-0572 | ||
| 2. | ||
Jean E. Grundy1, Mark A. Hancock2, Scott C. Meixner1, Roger C. MacKenzie3, Marlys L. Koschinsky2, Edward L. G. Pryzdial1 Thrombosis and Haemostasis 2007 97 1: 38-44 http://dx.doi.org/10.1160/TH06-08-0476 | ||
| 3. | ||
Ç. Ağar (1, 2), P. G. de Groot (2), J. A. Marquart (1), J. C. M. Meijers (3) Thrombosis and Haemostasis 2011 106 6: 1069-1075 http://dx.doi.org/10.1160/TH11-05-0333 | ||